Succession Selected by BCS for Market Access Risk Management

A London bus at St Paul's
BCS received authorization from the UK Financial Conduct Authority (FCA) in June.

Aimed at proprietary and high-frequency trading (HFT) clients, TripleCheck allows for minimized latency while retaining standard pre-trade risk functionality, such as fat-finger checks and margin calculations. Initial testing of the system, the vendor says, has resulted in a throughput of up to 10,000 orders per second. A real-time dashboard allows compliance officers to monitor the trade flow and adjust where necessary.

"To remain at the forefront of what we do, and to continue to exceed our clients' expectations, BCS is committed to bringing innovative solutions to the market to capitalize on the growing demand for fast and efficient trade flows with Russia," says Tim Bevan, head of international prime sales at BCS. "We are currently looking to add markets, specific asset classes, client-oriented functions and liquidity services, and our appointment of Succession Systems will ensure we are able to consistently deliver cost-efficient, fast, flexible and comprehensive solutions."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Waters Wrap: Examining ASX’s CHESS do-over

The Australian exchange was the first exchange to be all-in on DLT—and the project failed. Anthony speaks with ASX’s Tim Whiteley to discuss the lessons learned and why he thinks the second attempt will succeed.

GenAI and HFT: A competitive edge?

Timing is critical in the capital markets. IBM researchers say genAI’s predictive abilities in combination with AI/ML models can translate into profitable HFT opportunities.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here